JPRN-UMIN000010621招募中2 期
Phase II study of efficacy and safety of duloxetine for chlonic oxaliplatin-induced peripheral neuropathy in metastatic colorectal cancer - Phase II study of efficacy and safety of duloxetine for chlonic oxaliplatin-induced peripheral neuropathy
Osaka City General Hospital Department of Clinical Oncology0 个研究点目标入组 20 人开始时间: 2013年7月2日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)having other active malignancies 2) severe complications (uncontrolled diabetes mellitus, interstitial lung disease, pulmonary fibrosis, heart failure ,renal failure, hepatic failure, etc.) 3) having active infections 4) history of severe drug hypersensitivity 5) uncontrollable serious mental problem 7) pregnant or female intend to be pregnant, and male intend to make pregnant. 8) peripheral neuropathy>=Gr2 9)Others
研究者
相似试验
进行中（未招募）
不适用
A phase II study of the safety and efficacy of doxycycline administered cyclically in patients suffering from Transthyretin Amiloidosis ATTR - NDTransthyretin amyloidosis ATTRMedDRA version: 6.1Level: HLGTClassification code 10034606EUCTR2006-000012-24-ITOSPEDALE POLICLINICO S. MATTEO10
进行中（未招募）
不适用
A double-blind, efficacy and safety study of duloxetine versus placebo in the treatment of children and adolescents with major depressive disorderEUCTR2008-006492-71-DEEli Lilly and Company336
进行中（未招募）
1 期
A double-blind, efficacy and safety study of duloxetine versus placebo in the treatment of children and adolescents with major depressive disorderMajor depressive disorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSEUCTR2008-006492-71-FREli Lilly and Company336
进行中（未招募）
不适用
A double-blind, efficacy and safety study of duloxetine versus placebo in the treatment of children and adolescents with major depressive disorderMajor depressive disorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSEUCTR2008-006492-71-EEEli Lilly and Company336
进行中（未招募）
不适用
A double-blind, efficacy and safety study of duloxetine versus placebo in the treatment of children and adolescents with major depressive disorderMajor depressive disorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSEUCTR2008-006492-71-FIEli Lilly and Company336